Lloyd A - Search Results

1

A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany.

Xue W, Lloyd A, Falla E, Roeder C, Papsch R, Bühler K. Xue W, et al. Among authors: lloyd a. Int J Womens Health. 2019 May 13;11:319-331. doi: 10.2147/IJWH.S193048. eCollection 2019. Int J Womens Health. 2019. PMID: 31191040 Free PMC article.

2

Cost-effectiveness comparison of tizanidine and baclofen in the management of spasticity.

Rushton DN, Lloyd AC, Anderson PM. Rushton DN, et al. Pharmacoeconomics. 2002;20(12):827-37. doi: 10.2165/00019053-200220120-00003. Pharmacoeconomics. 2002. PMID: 12236804 Clinical Trial.

3

Cost-effectiveness of low-level heat wrap therapy for low back pain.

Lloyd A, Scott DA, Akehurst RL, Lurie-Luke E, Jessen G. Lloyd A, et al. Value Health. 2004 Jul-Aug;7(4):413-22. doi: 10.1111/j.1524-4733.2004.74004.x. Value Health. 2004. PMID: 15449633 Free article.

4

Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK.

Lloyd A, Townsend C, Munro V, Twena N, Nielsen S, Holman A. Lloyd A, et al. Curr Med Res Opin. 2009 Mar;25(3):599-605. doi: 10.1185/03007990802668208. Curr Med Res Opin. 2009. PMID: 19232034 Clinical Trial.

5

Fluconazole versus oral polyenes in the prophylaxis of immunocompromised patients: a cost-minimization analysis.

Wakerly L, Craig AM, Malek M, Hoffmeyer U, Lloyd A, Valette F, Phillips R, Zabihollah M. Wakerly L, et al. Among authors: lloyd a. J Hosp Infect. 1996 May;33(1):35-48. doi: 10.1016/s0195-6701(96)90027-4. J Hosp Infect. 1996. PMID: 8738200

6

Costs and outcomes associated with IVF using recombinant FSH.

Ledger W, Wiebinga C, Anderson P, Irwin D, Holman A, Lloyd A. Ledger W, et al. Among authors: lloyd a. Reprod Biomed Online. 2009 Sep;19(3):337-42. doi: 10.1016/s1472-6483(10)60167-8. Reprod Biomed Online. 2009. PMID: 19778478

7

A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial.

Lloyd A, Holman A, Evers T. Lloyd A, et al. Curr Med Res Opin. 2008 May;24(5):1279-84. doi: 10.1185/030079908x280400. Epub 2008 Mar 20. Curr Med Res Opin. 2008. PMID: 18358083 Clinical Trial.

8

Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.

Lloyd A, Patel N, Scott DA, Runge C, Claes C, Rose M. Lloyd A, et al. Eur J Health Econ. 2008 Feb;9(1):7-15. doi: 10.1007/s10198-006-0013-6. Epub 2007 Mar 2. Eur J Health Econ. 2008. PMID: 17333089

9

Cost effectiveness of olanzapine in prevention of affective episodes in bipolar disorder in the United Kingdom.

McKendrick J, Cerri KH, Lloyd A, D'Ausilio A, Dando S, Chinn C. McKendrick J, et al. Among authors: lloyd a. J Psychopharmacol. 2007 Aug;21(6):588-96. doi: 10.1177/0269881106068395. Epub 2006 Oct 18. J Psychopharmacol. 2007. PMID: 17050661 Clinical Trial.

10

Economic evaluation of etanercept in the management of chronic plaque psoriasis.

Lloyd A, Reeves P, Conway P, Reynolds A, Baxter G. Lloyd A, et al. Br J Dermatol. 2009 Feb;160(2):380-6. doi: 10.1111/j.1365-2133.2008.08863.x. Epub 2008 Sep 19. Br J Dermatol. 2009. PMID: 18808413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,925 results

Search Page

Filters